VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Inspirna, Inc.
M.D. Anderson Cancer Center
University of California, San Francisco
Kezar Life Sciences, Inc.
Sotio Biotech Inc.
Alaunos Therapeutics
Incyte Corporation
Day One Biopharmaceuticals, Inc.
Enterome
NuCana plc
Institut Bergonié
Sotio Biotech Inc.
Hoosier Cancer Research Network
Bristol-Myers Squibb
Hutchmed
SafeHeal Inc
University of Florida
Gilead Sciences
Numab Therapeutics AG
Daiichi Sankyo
Hutchmed
Thomas Jefferson University
University of Utah
M.D. Anderson Cancer Center
Black Diamond Therapeutics, Inc.
Elevation Oncology
Boehringer Ingelheim
Georgetown University
Boehringer Ingelheim
Merck Sharp & Dohme LLC
Pfizer
ImmunityBio, Inc.
Highlight Therapeutics
G1 Therapeutics, Inc.
Merck Sharp & Dohme LLC
MEI Pharma, Inc.
AstraZeneca
NantCell, Inc.
Servier
Pfizer
Federation Francophone de Cancerologie Digestive
Wake Forest University Health Sciences
Pfizer
University of Pennsylvania
Kyowa Kirin Co., Ltd.
Pfizer
Spectrum Pharmaceuticals, Inc
Eisai Inc.